๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide

โœ Scribed by G. Wei Xu; Joe S. Mymryk; J. Gregory Cairncross


Book ID
102272572
Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
261 KB
Volume
116
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Pifithrinโ€ฮฑ (PFTฮฑ) is a small molecule inhibitor of p53. By reversibly blocking apoptosis in response to DNA damage, PFTฮฑ protects normal cells from lethal doses of ฮณโ€radiation (Komarov et al., Science, 1999;285:1733โ€“7). We examined the effect of PFTฮฑ on the chemosensitivity of a human cancer in which cell cycle arrest, not apoptosis, is the principle cellular consequence of p53 activation. This was of interest because E6 silencing of p53 sensitizes U87MG astrocytic glioma cells to BCNU and temozolomide (TMZ), cytotoxic drugs that are modestly helpful in the treatment of aggressive astrocytic gliomas. We observed that exposure of U87MG cells to PFTฮฑ before cytotoxic chemotherapy attenuated p53โ€mediated induction of p21WAF1 protein levels, sensitizing U87MG cells to BCNU and TMZ. Sensitization of U87MG cells was associated with G1 arrest, delayed entry into Sโ€phase and decreased repair of DNA damage by BCNU. Our findings suggest that in addition to protecting normal cells from the toxic effects of radiation and chemotherapy, small molecule inhibitors of p53, like PFTฮฑ, might play a role in clinical oncology by sensitizing certain resistant cancers to cytotoxic chemotherapies. ยฉ 2005 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES